VEROVACCINES
VEROVACCiNES discovers and develops innovative vaccine solutions, to protect animals against infectious diseases. Key is a novel, broadly applicable, yeast-based technology to generate subunit marker vaccines. This technology has been validated by demonstrating protection of several target animal species against different viral diseases (proof-of-concept). VEROVACCiNES GmbH is a spin-off company of the Martin Luther University Halle-Wittenberg, Germany in 2017. The company exclusively took over... IP, brand, team, products and know-how from the former BMBF GO-Bio-funded VEROVACCiNES project at Halle University. VEROVACCiNES GmbH is eligible for follow-up phase 2 funding from the same BMBF GO-Bio program. They cooperate closely with veterinary pharmaceutical companies, universities and research institutes, and they are eager to initiate new collaborations.
VEROVACCINES
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2017-01-01
Address:
Halle, Niedersachsen, Germany
Country:
Germany
Website Url:
http://www.verovaccines.org
Total Employee:
11+
Status:
Active
Contact:
+49 345 5526309
Total Funding:
3.1 M EUR
Technology used in webpage:
SPF Apple Mobile Web Clips Icon IPv6 Microsoft Exchange Online Office 365 Mail IONOS 1and1
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
i2 Pharmaceuticals
i2 Pharmaceuticals, a biopharmaceutical company.
IntraBio
IntraBio is a biopharmaceutical company.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Current Employees Featured
Founder
Investors List
German Federal Ministry of Education and Research
German Federal Ministry of Education and Research investment in Series B - Verovaccines
German Federal Ministry of Education and Research
German Federal Ministry of Education and Research investment in Seed Round - Verovaccines
Business Angels Switzerland (BAS)
Business Angels Switzerland (BAS) investment in Seed Round - Verovaccines
HTGF | High-Tech Gruenderfonds
HTGF | High-Tech Gruenderfonds investment in Seed Round - Verovaccines
German Federal Ministry of Education and Research
German Federal Ministry of Education and Research investment in Grant - Verovaccines
Official Site Inspections
http://www.verovaccines.org
- Host name: 217-160-0-5.elastic-ssl.ui-r.com
- IP address: 217.160.0.5
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Verovaccines"
VEROVACCiNES GmbH
Verovaccines built an integrated subunit vaccine platform to rapidly create, optimize and develop animal vaccines. Our platform brings vaccines to registration quickly and offers unique …See details»
Verovaccines - Crunchbase Company Profile & Funding
Verovaccines is a biopharmaceutical company. VEROVACCiNES discovers and develops innovative vaccine solutions, to protect animals against infectious diseases. Key is a novel, broadly applicable, yeast-based technology to …See details»
VEROVACCiNES GmbH - LinkedIn
We are developing vaccine solutions for poultry, swine and ruminants. VEROVACCiNES is engaged in collaborations with market leaders as well as with academic institutions....See details»
VEROVACCiNES Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for VEROVACCiNES. Use the PitchBook Platform to explore the full profile.See details»
Verovaccines - EU-Startups
VEROVACCiNES develops and markets a novel class of innovative, proprietary subunit marker vaccines for animal health. The technology provides a validated solution to the industry's need …See details»
VEROVACCiNES GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for VEROVACCiNES GmbH of Halle (Saale), Sachsen-Anhalt. Get the latest business insights …See details»
New development phase for the Verovaccines company
Following the validation of its new vaccine and manufacturing platforms, Verovaccines is expanding its portfolio with new mono- and combination vaccines.See details»
VEROVACCiNES (GO-Bio funded) - uni-halle.de
May 28, 2024 · VEROVACCiNES (GO-Bio funded) Based on Kluyveromyces lactis, a yeast, holding the so-called GRAS-status (generally recognized as safe), we developed a simple, …See details»
Verovaccines develops vaccine to fully protect animals against viral ...
Verovaccines develops vaccine to fully protect animals against viral infections Copyright: Marco Warmuth/Verocaccines / Laboratory work with yeast-based vaccine candidates Verovaccines …See details»
VEROVACCiNES GmbH on LinkedIn: #verovaccines #development …
Verovaccines is currently evaluating different strategic options to support the company’s growth path and bring its new vaccines to market as quickly as possible. #animalhealth #vaccines...See details»
Videoporträt: VEROVACCiNES – 2019 - BMBF
Die Impfstoffplattform basiert auf einen völlig neuen Ansatz: Hierbei werden gentechnisch veränderte Stämme der Milchhefe zur Herstellung von Viren genutzt. Mit dieser Idee gehörte …See details»
Verovaccines achieves full protection of animals against viral ...
Mar 8, 2021 · Verovaccines GmbH, a German company specialising on the development of next-generation, multi-valent yeast vaccines for animals, has achieved proof-of-concept in its fourth …See details»
EMA starts rolling review of COVID-19 Vaccine (Vero Cell) …
May 4, 2021 · EMA’s human medicines committee (CHMP) has started a rolling review of COVID-19 Vaccine (Vero Cell) Inactivated, developed by Sinovac Life Sciences Co., Ltd. The EU …See details»
Vero cell upstream bioprocess development for the production of …
Nov 15, 2020 · Herein, we review the prevailing literature on Vero cell bioprocess development for the production of viral vectors and vaccines with the aim to assess the recent advances in …See details»
Vero cell platform in vaccine production: moving towards cell …
Jan 9, 2014 · The Vero cell line is the most widely accepted CCL by regulatory authorities and has been used for over 30 years for the production of polio and rabies virus vaccines.See details»
Sinopharm [Vero Cell]- Inactivated, COVID-19 vaccine
Jun 3, 2022 · The SARS-CoV-2 Vaccine (VeroCell) is an inactivated vaccine against coronavirus disease 2019 (COVID-19) which stimulates the body’s immune system without risk of causing …See details»
Effectiveness of the Inactivated SARS-CoV-2 (Vero Cell) Vaccine in ...
Aug 26, 2022 · In February 2021, the Ministry of Health of Peru approved the emergency use of the inactivated SARS-CoV-2 (Vero Cell) vaccine and initiated vaccination with health …See details»
Sinovac CoronaVac® [Vero Cell]- Inactivated, COVID-19 vaccine
The COVID-19 Vaccine (Vero Cell) Inactivated, CoronaVac vaccine resource includes key information on the vaccine specific requirements.See details»
COVID-19 Vaccines: Authorized vaccines - Canada.ca
Information on COVID-19 vaccines including approved vaccines, types of vaccines and on-going safety monitoring. About the vaccine, how it works, how it is given, ingredients, allergies, …See details»
COVID-19 Vaccine Explainer - World Health Organization
The SARS-CoV-2 Vaccine (VeroCell) is an inactivated vaccine against coronavirus disease 2019 (COVID-19) which stimulates the body’s immune system without risk of causing disease.See details»